Osteolytic lesions in patients with relapse of diffuse large B-cell lymphoma treated with lenalidomide

被引：0
|
作者：
Schuelper, Nikolai [1 ]
Flohr, Antonius [2 ]
Truemper, Lorenz [1 ]
Wulf, Gerald G. [1 ]
机构：
[1] Univ Gottingen, Dept Hematol & Oncol, D-37075 Gottingen, Germany
[2] Univ Gottingen, Dept Radiol, D-37075 Gottingen, Germany
来源：
ANNALS OF HEMATOLOGY | 2014年 / 93卷 / 11期
关键词：
MONOTHERAPY;
D O I：
10.1007/s00277-014-2071-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1929 / 1930
页数：2
相关论文
共 38 条
  • [31] Safety, tolerability and pharmacokinetics of shorter duration of infusion of obinutuzumab in Japanese patients with B-cell non-Hodgkin lymphoma: final results of the phase II GATS study
    Ohmachi, Ken
    Ando, Kiyoshi
    Kinoshita, Tomohiro
    Kumagai, Kyoya
    Hatake, Kiyohiko
    Ishikawa, Takayuki
    Teshima, Takanori
    Kato, Koji
    Izutsu, Koji
    Ueda, Eisuke
    Nakai, Kiyohiko
    Kuriki, Hiroshi
    Tobinai, Kensei
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (08) : 736 - 742
  • [32] Anti-CD79B Antibody-Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1; Dose-Escalation Study
    Herrera, Alex F.
    Patel, Manish R.
    Burke, John M.
    Advani, Ranjana
    Cheson, Bruce D.
    Sharman, Jeff P.
    Penuel, Elicia
    Polson, Andrew G.
    Di Liao, Chen
    Li, Chunze
    Schuth, Eva
    Vaze, Anjali
    Samineni, Divya
    Elstrom, Rebecca
    Cooper, James
    Diefenbach, Catherine
    CLINICAL CANCER RESEARCH, 2022, 28 (07) : 1294 - 1301
  • [33] Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study
    Nowakowski, G. S.
    LaPlant, B.
    Habermann, T. M.
    Rivera, C. E.
    Macon, W. R.
    Inwards, D. J.
    Micallef, I. N.
    Johnston, P. B.
    Porrata, L. F.
    Ansell, S. M.
    Klebig, R. R.
    Reeder, C. B.
    Witzig, T. E.
    LEUKEMIA, 2011, 25 (12) : 1877 - 1881
  • [34] Safety and efficacy of obinutuzumab in Chinese patients with B-cell lymphomas: a secondary analysis of the GERSHWIN trial
    Qin, Yan
    Song, Yuqin
    Shen, Zhixiang
    Du, Xin
    Ji, Wei
    Hsu, Wanling
    Zhu, Jun
    Shi, Yuankai
    CANCER COMMUNICATIONS, 2018, 38
  • [35] A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B-cell lymphomas
    Vannata, Barbara
    Vanazzi, Anna
    Negri, Mara
    Liptrott, Sarah Jayne
    Bartosek, Anna Amalia
    Miani, Monica
    Di Sanzo, Alessandro
    Cavalli, Franco
    Zucca, Emanuele
    Stathis, Anastasios
    HEMATOLOGICAL ONCOLOGY, 2021, 39 (01) : 60 - 65
  • [36] Avadomide plus obinutuzumab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (CC-122-NHL-001): a multicentre, dose escalation and expansion phase 1 study
    Michot, Jean-Marie
    Bouabdallah, Reda
    Vitolo, Umberto
    Doorduijn, Jeanette K.
    Salles, Gilles
    Chiappella, Annalisa
    Zinzani, Pier Luigi
    Bijou, Fontanet
    Kersten, Marie Jose
    Sarmiento, Rafael
    Mosulen, Silvia
    Mendez, Cristina
    Uttamsingh, Shailaja
    Pourdehnad, Michael
    Hege, Kristen
    Chen, Tianlei
    Klein, Christian
    Hagner, Patrick R.
    Nikolova, Zariana
    Ribrag, Vincent
    LANCET HAEMATOLOGY, 2020, 7 (09): : E649 - E659
  • [37] Multifocal polyclonal Epstein-Barr virus-associated B-cell lymphoproliferative disorder secondary to azathioprine therapy successfully treated with rituximab
    Courby, Stephane
    Fabre, Blandine
    Salameire, Dimitri
    Gaulard, Philippe
    Hincky-Vitrat, Virginie
    Gressin, Remy
    Bonaz, Bruno
    Epaulard, Olivier
    LEUKEMIA & LYMPHOMA, 2010, 51 (01) : 174 - 177
  • [38] A phase 1/2 trial of ublituximab, a novel anti-CD20 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab
    Sawas, Ahmed
    Farber, Charles M.
    Schreeder, Marshall T.
    Khalil, Mazen Y.
    Mahadevan, Daruka
    Deng, Changchun
    Amengual, Jennifer E.
    Nikolinakos, Petros G.
    Kolesar, Jill M.
    Kuhn, John G.
    Sportelli, Peter
    Miskin, Hari P.
    O'Connor, Owen A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 177 (02) : 243 - 253
1234